Papers on statin intolerance

42 papers7 new in 30 days

Thursday, October 29

Nutrition, Metabolism, and Cardiovascular DiseasesOct 29

Cross-sectional study in a lipoprotein apheresis centre: a thirty-year history of Practice, Investigation and Struggle against Atherosclerotic disease (P.I.S.A.)

Cross-sectional study of 92 peopleAtherosclerosis

Paper

Tuesday, October 27

Giornale Italiano Di CardiologiaOct 27

Role of statin/ezetimibe fixed-dose combination in lipid risk management in the cardiovascular disease continuum

ReviewStatin + ezetimibe

Paper

Monday, October 26

ESC Congress 2026 AbstractOct 26

Lipid-lowering therapy use and LDL-C goal achievement in patients with hypercholesterolaemia or mixed dyslipidaemia in Hong Kong: findings from a retrospective database study

Cross-sectional study of 814,451 peopleHypercholesterolemia

Paper

ESC Congress 2026 AbstractOct 26

Predicted change in 10-year cardiovascular risk one year after initiation of bempedoic acid-based therapy in the MILOS study

Cohort study of 960 peopleBempedoic acid

Paper

ESC Congress 2026 AbstractOct 26

Perceived effectiveness of PCSK9i-SiRNA therapy and adherence to background statin therapy: real-world analysis of the DAMAGE registry

Cohort study of 403 peopleStatins

Paper

Thursday, October 8

Journal of Clinical LipidologyOct 8

Safety and tolerability of nonstatin LDL-cholesterol-lowering therapies: A systematic review and pairwise meta-analysis of randomized controlled trials

Meta-analysis of randomized trialsInterventions

Paper

Thursday, October 1

Endocrinology, Diabetes & MetabolismOct 1

Efficacy and Safety of Oral Non-Statin Lipid-Lowering Therapies in Dyslipidaemia: A Systematic Review and Network Meta-Analysis

Meta-analysisDyslipidemia

Paper

Tuesday, September 29

Clinical Research in CardiologySep 29

Long-term LDL-C lowering and treatment persistence with inclisiran: 3-year follow-up from the German Inclisiran Network

Cohort study of 109 peopleInclisiran

Paper

Thursday, September 24

ReportsSep 24

The Utilization of Inclisiran for the Optimization of Lipid Management in People Living with HIV: A Clinical Case Series and Comprehensive Review

Case seriesInclisiran

Paper

Saturday, September 19

Methodist DeBakey Cardiovascular JournalSep 19

Familial Hypercholesterolemia

ReviewFamilial hypercholesterolemia

Paper

Thursday, September 17

Journal of Clinical LipidologySep 17

Management of complex lipid disorders in a community lipid clinic setting: Implementing a multidisciplinary model

Cohort study of 183 peopleInterventions

Paper

Tuesday, September 15

Annals of Internal MedicineSep 15

A Synopsis of the 2025 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline for Lipid Management for Cardiovascular Disease Risk Reduction

CommentaryIndustry & policy

Paper

Tuesday, September 8

Frontiers in MedicineSep 8

Contemporary non-statin therapies for dyslipidemia management: achieving current lipid targets

Mechanisms of action of non-statin therapies across cholesterol metabolism.

ReviewDyslipidemia

Paper

Friday, September 4

Reviews in Cardiovascular MedicineSep 4

A New Option for the Management of Dyslipidemias: Advances in Research on the Small Interfering RNA Drug Inclisiran

ReviewInclisiran

Paper

Thursday, September 3

Nihon Yakurigaku Zasshi Folia Pharmacologica JaponicaSep 3

Pharmacological properties and clinical efficacy of bempedoic acid (NEXLETOL® tablets 180 mg) for the treatment of hypercholesterolemia

ReviewBempedoic acid

Paper

Tuesday, August 18

CirculationAug 18

Bempedoic Acid and First and Recurrent Limb Outcomes in Statin-Intolerant Patients With Peripheral Artery Disease: Insights From the CLEAR Outcomes Trial

Randomized trial in 13,970 peopleBempedoic acid

Paper

Tuesday, August 11

Journal of Clinical LipidologyAug 11

Effectiveness, safety, and treatment persistence of bempedoic acid in a Spanish real-world cohort

Cohort study of 814 peopleBempedoic acid

Paper

Saturday, March 28

PharmaceuticalsMar 28

Pharmacogenetic Associations with Statin Regimen Modification, Intolerance, and Adverse Outcomes in Coronary Artery Disease Patients

Cohort study of 911 peopleStatins

Paper

Friday, March 13

Minerva Cardiology and AngiologyMar 13

Lipid-lowering therapies: the arrows in the quiver and future bullets

ReviewInterventions

Paper

Journal of Clinical LipidologyMar 13

Bempedoic acid vs ezetimibe added to statin therapy: Cardiovascular outcomes in the real-world-The BEYOND-REAL Study

Cohort study of 6,706 peopleBempedoic acid

Paper

Monday, February 9

Journal of Lipid and AtherosclerosisFeb 9

Prevalence of Statin Intolerance in a Primary Care Portuguese Population: A Retrospective Cohort Study

Cohort study of 12,393 peopleStatins

Paper

Thursday, January 1

Cardiology Research and PracticeJan 1